Head-to-head · WeighScore
Gimme Care vs Mint Med
By GLP-1 ScorecardUpdated
Score comparison
Gimme Care has the higher recorded score — 84.6/100 to 78.7/100.
Gimme Care grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Bundled compounded injections with lower advertised rates on longer plans; confirm the initial charge and renewal dates.
Before you choose
Mint Med does not publish a semaglutide price, so its Mint Med review sets out what it does disclose, while the Gimme Care review explains the conditions attached to Gimme Care's figure. The semaglutide cost page compares published rates across the field. Ask Mint Med for a written total before treating either one as the cheaper choice.
If neither one fits, Gimme Care vs NextMeds and Invigor Medical vs Mint Med compare each of them with another graded program, and the list of alternatives to Gimme Care ranks the programs closest to Gimme Care on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Eden review covers one graded close to these two, at 81.6/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Gimme Care | Mint Med |
|---|---|---|
| WeighScore | 84.6/100 | 78.7/100 |
| Grade | B | C+ |
| Site position | #15 | #44 |
| Semaglutide | $160 one-month plan; $130/month on three-month plan or $119/month on six-month plan; confirm initial charge and renewal dates | Product and catalog prices conflict; confirm selected plan charge and supply. |
| Tirzepatide | $199 one-month plan; $163/month on three-month plan or $149/month on six-month plan; confirm initial charge and renewal dates | Catalog title and starting price differ; confirm selected charge and supply. |
| Coverage | Advertises all 50 states plus DC; state-specific initial audio/video requirements apply | Homepage says 35 states but lists 36; confirm treatment-specific eligibility. |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Portal pause or cancellation
- Pre-dispense order cancellation
- Unavailable-treatment refund exception
What to consider
- Assigned pharmacy not established
- Support-change notice required
- Refund eligibility is conditional
FDAWarning letter issued to Glow Medispa, LLC dba Mint Med in June 2026. See the FDA warning-letter database.
Strengths
- Published monthly and prepaid plan choices
- Portal access for treatment questions
What to consider
- Advertised prices conflict
- Processed orders generally final
- Prepaid cancellation can require repricing
- Assigned pharmacy and clinician need confirmation
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.